Made by Square Pharmaceuticals PLC., Ticalog is a tablet whose active ingredient is Ticagrelor. It is taken alongside daily aspirin as part of the treatment plan set by the doctor.
There are 13 brands of Ticagrelor listed in Bangladesh. 3 of them have a lower unit price than Ticalog. The lowest listed price is Belinta 60 mg Tablet at ৳ 35.00 per unit.
What is Ticalog 90 mg Tablet?
Ticalog comes as a tablet with 90 mg of Ticagrelor, from Square Pharmaceuticals PLC. Ticalog is taken together with aspirin. Ticagrelor works by reducing platelet activation and clumping in the blood. The doctor decides the dose and course.
Uses of Ticalog
It is taken alongside daily aspirin as part of the treatment plan set by the doctor. This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction. Ticalog is used in adults to help prevent atherothrombotic events after an acute coronary syndrome. Your doctor will decide if it is suitable for you.
How to use Ticalog
Ask the doctor about the dose and course. Ticalog is taken by mouth. Swallow the tablet with water. Take Ticalog exactly as your doctor or pharmacist tells you. If you miss a dose, ask the doctor or pharmacist what to do; the product information advises taking only the next scheduled tablet and not doubling up. Do not change the dose or stop early without asking your doctor.
Side effects of Ticalog
Common side effects that have been reported with Ticagrelor include shortness of breath, bleeding, headache, cough, dizziness, nausea, diarrhoea, back pain, fatigue, chest pain, low blood pressure, high blood pressure and atrial fibrillation. The doctor can advise whether you need review or a change in treatment. Because it affects platelets, bleeding is a particular concern. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
Some other medicines, including certain antifungals, antibiotics and seizure medicines, should not be combined with it. It is not for people with moderate to severe liver problems or with allergies to the ingredients. Ticalog increases the risk of bleeding, so tell the doctor about any bleeding problem, peptic ulcer or past bleeding in the brain. Tell your doctor about all the other medicines you take.
Frequently asked questions
What is Ticalog used for?
It is taken alongside daily aspirin as part of the treatment plan set by the doctor. This includes unstable angina, non-ST elevation myocardial infarction and ST elevation myocardial infarction.
How should I take Ticalog?
Ask the doctor about the dose and course. Ticalog is taken by mouth.
What should I watch for while using Ticalog?
Common side effects that have been reported with Ticagrelor include shortness of breath, bleeding, headache, cough, dizziness, nausea, diarrhoea, back pain, fatigue, chest pain, low blood pressure, high blood pressure and atrial fibrillation. The doctor can advise whether you need review or a change in treatment.
Ticagrelor is indicated for the prevention of atherothrombotic events in adult patients with Acute Coronary Syndromes (unstable angina, non ST elevation Myocardial Infarction [NSTEMI] or ST elevation Myocardial Infarction [STEMI]); including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass grafting (CABG).
Pharmacology
Ticagrelor is a selective adenosine diphosphate (ADP) receptor antagonist acting on the P2Y12 ADP-receptor that can prevent ADP-mediated platelet activation and aggregation. Ticagrelor reversibly interacts with the platelet P2Y12 ADP-receptor.Ticagrelor does not interact with the ADP binding site itself, but interacts with platelet P2Y12 ADP-receptor to prevent signal transduction.Thus it prevents platelet activation & aggregation.
Dosage & Administration
Ticagrelor treatment should be initiated with a single 180 mg loading dose (two tablets of 90 mg) and then continued at 90 mg twice daily. Patients taking Ticagrelor should also take aspirin daily, unless specifically contraindicated. Following an initial dose of aspirin (usually 325 mg), Ticagrelor should be used with a maintenance dose of aspirin of 75-100 mg. Maintenance dose of Aspirin above 100 mg decreased the efficacy of Ticagrelor. So, maintenance dose of aspirin above 100 mg should be avoided.
A patient who misses a dose of Ticagrelor should take only one 90 mg tablet (the next dose) at its scheduled time. Patients treated with Clopidogrel can be directly switched to Ticagrelor if needed. Switching from prasugrel to ticagrelor has not been investigated.
Treatment is recommended for up to 12 months unless discontinuation of Ticagrelor is clinically indicated. Ticagrelor can be administered with or without food.
Interaction
CYP3A inhibitors: Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin).
CYP3A inducers: Avoid use with potent inducers of CYP3A (e.g., rifampin, dexamethasone, phenytoin,carbamazepine and phenobarbital).
Aspirin: Use of Ticagrelor with aspirin maintenance doses above 100 mg reduced the effectiveness ofTicagrelor.
Simvastatin, Lovastatin: Ticagrelor will result in higher serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4. Avoid simvastatin and lovastatin doses greater than 40 mg.
Digoxin: Because of inhibition of the P-glycoprotein transporter, monitor digoxin levels with initiation of or any change in ticagrelor therapy.
Other Concomitant Therapy: Ticagrelor can be administered with unfractionated or low-molecular-weight heparin, GPIIb/llla inhibitors, proton pump inhibitors, beta-blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers.
Contraindications
Ticagrelor is contraindicated in case of-
Hypersensitivity to Ticagrelor or to any of the excipients
Active pathological bleeding (peptic ulcer)
History of intracranial haemorrhage
Moderate to severe hepatic impairment
Co-administration of Ticagrelor with strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin, nefazodone, ritonavir, and atazanavir)
Pregnancy category C. There are no or limited amount of data from the use of Ticagrelor in pregnant women.Ticagrelor is not recommended during pregnancy.
Nursing mothers: Available pharmacodynamic/toxicological data in animals have shown excretion of Ticagrelor and its active metabolites in milk. A risk to newborns/infants cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from ticagrelor therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the women.
Precautions & Warnings
General Risk of Bleeding: Drugs that inhibit platelet function including Ticagrelor increase the risk of bleeding.
Concomitant Aspirin Maintenance Dose: Use of Ticagrelor with maintenance doses of aspirin above 100 mg decreased the effectiveness of Ticagrelor. Therefore, after the initial loading dose of aspirin (usually 325 mg), use Ticagrelor with a maintenance dose of aspirin of 75-100 mg.
Moderate Hepatic Impairment: Ticagrelor has not been studied in patients with moderate hepatic impairment.
Discontinuation of Ticagrelor: Discontinuation of Ticagrelor will increase the risk of myocardial infarction, stent thrombosis, and death.
Overdose Effects
There is currently no known antidote to reverse the effects ofTicagrelor and it is not expected to be dialysable.Treatment of overdose should follow local standard medical practice.The expected effect of excessive ticagrelor dosing is prolonged duration of bleeding risk associated with platelet inhibition. If bleeding occurs appropriate supportive measures should be taken.
Storage Conditions
Protect from light & moisture. Store below 25° C. Keep out of reach of children.
Alternative brands of Ticagrelor
Other brands with the same generic name, cheapest first.